Kathleen Sullivan to Nitro Compounds
This is a "connection" page, showing publications Kathleen Sullivan has written about Nitro Compounds.
Connection Strength
0.247
-
Perelygina L, Buchbinder D, Dorsey MJ, Eloit M, Hauck F, Hautala T, Moshous D, Uriarte I, Deripapa E, Icenogle J, Sullivan KE. Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma. J Clin Immunol. 2019 01; 39(1):112-117.
Score: 0.169
-
Hautala TJ, Perelygina L, Vuorinen T, Hautala NM, H?gg PM, Bode MK, Rusanen HT, Renko MH, Glumoff V, Schwab N, Schneider-Hohendorf T, Murk JL, Sullivan KE, Sepp?nen MRJ. Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy. J Clin Immunol. 2018 01; 38(1):4-6.
Score: 0.039
-
Perelygina L, Hautala T, Sepp?nen M, Adebayo A, Sullivan KE, Icenogle J. Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency. Antiviral Res. 2017 Nov; 147:58-66.
Score: 0.039